Fast Five Quiz: Coronary Artery Atherosclerosis Management

Arnold S. Baas, MD

Disclosures

May 06, 2022

Primary prevention of cardiovascular disease with BP-lowering medications is recommended for adults with an estimated 10-year ASCVD risk of ≥ 10% and an average BP of ≥ 130/80 mm Hg.

A BP target of < 130/80 mm Hg is recommended for adults with confirmed hypertension and a 10-year ASCVD event risk of ≥ 10%.

Additionally, treatment to a BP goal of < 130/80 mm Hg is recommended for adults with hypertension and chronic kidney disease, regardless of 10-year ASCVD risk score.

In adults with type 2 diabetes and hypertension, antihypertensive drug therapy should be administered to those who have a BP of ≥ 130/80 mm Hg, with the goal being to reduce BP to < 130/80 mm Hg.

Learn more about the prevention of ASCVD.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....